NASDAQ
Celyad Oncology S.A. (CLYYF) has a interest coverage ratio of -112.22x as of Wednesday, July 15, 2026. This represents a 4.64% increase compared to its 12-month average of -117.69x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.